CIK 0001858848
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Tenaya Therapeutics, Inc.
Sign in to watch- Ticker
- TNYA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813789973
- Phone
- +1 415-865-2066
- Business address
- 171 OYSTER POINT BLVD., SUITE 500, SOUTH SAN FRANCISCO, CA, 94080
- 8-K Event Delisting notice
- DEF 14A Proxy Proxy Statement
- 8-K Event Exit or restructuring costs
- 10-K Report Annual Report
- 8-K Event Results of operations
- 8-K Event Material agreement · Regulation FD disclosure · Other events
- 8-K Event Executive or director change
- 8-K Event Executive or director change
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Executive or director change
- 8-K Event Results of operations
- 8-K Event Executive or director change
- 8-K Event Results of operations · Executive or director change
- 8-K Event Executive or director change
- 8-K Event Executive or director change
- 8-K Event Shareholder vote results
- 8-K Event Results of operations · Exit or restructuring costs
- DEF 14A Proxy Proxy Statement
- 10-K Report Annual Report
- 8-K Event Results of operations
Page 2 of 4 · 65 filings